|
Volumn 59, Issue 3, 2008, Pages 279-281
|
Lung cancer during pregnancy: An emerging issue
|
Author keywords
Foetus involvement; Lung cancer; Placenta involvement; Pregnancy; Prognosis; Treatment
|
Indexed keywords
ALKYLATING AGENT;
ANTHRACYCLINE DERIVATIVE;
ANTIMETABOLITE;
ANTINEOPLASTIC AGENT;
CISPLATIN;
DNA TOPOISOMERASE INHIBITOR;
DOCETAXEL;
ETOPOSIDE;
GEMCITABINE;
NAVELBINE;
PLATINUM DERIVATIVE;
TAXANE DERIVATIVE;
CANCER CHEMOTHERAPY;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER STAGING;
CANCER SURVIVAL;
CARCINOGENESIS;
CIGARETTE SMOKING;
CONGENITAL MALFORMATION;
EDITORIAL;
FIRST TRIMESTER PREGNANCY;
GROWTH RETARDATION;
HUMAN;
INFERTILITY;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
METASTASIS;
MULTIPLE CYCLE TREATMENT;
MUTATION;
PREGNANCY;
PRIORITY JOURNAL;
PROGNOSIS;
SIDE EFFECT;
SPONTANEOUS ABORTION;
TERATOGENESIS;
ADULT;
ANTINEOPLASTIC AGENTS;
FEMALE;
HUMANS;
INCIDENCE;
LUNG NEOPLASMS;
MIDDLE AGED;
PREGNANCY;
PREGNANCY COMPLICATIONS, NEOPLASTIC;
RISK FACTORS;
SMOKING;
|
EID: 40249108434
PISSN: 01695002
EISSN: None
Source Type: Journal
DOI: 10.1016/j.lungcan.2007.10.010 Document Type: Editorial |
Times cited : (30)
|
References (8)
|